Assays / Heart
Heart
Cardiac Marker Panel — cTnI, CK-MB and Myoglobin Multiplex Assay
A planned multiplex strip that reports troponin I, CK-MB and myoglobin quantitatively from one sample on the OncoFirm reader.
At a glance
Targets
Cardiac troponin I, CK-MB and myoglobin
Sample
Whole blood or plasma
Readout
Quantitative value for each marker (planned)
Status
Planned
Why it matters
Clinical context
Emergency and outpatient teams sometimes look at more than one cardiac marker, but troponin remains the basis of heart-attack diagnosis. A panel read by one instrument keeps all three values in one record, with clinical decisions following troponin-based guidelines.
How OncoFirm will measure it
Built on the OncoFirm fluorescent platform
Three values, one record
The platform’s multiplex design is intended to measure each marker separately and store them together.
A strip that checks itself
Every strip carries a fluorescent reference line of known brightness. Reading the test line against it corrects for reader and temperature drift, and the reader flags runs that did not flow correctly.
A traceable digital record
Each result is stored with the date, operator and lot, ready to share with a clinic record or laboratory system instead of being retyped by hand.
Where it's headed
Development roadmap
01
Feasibility
Antibody pairs, fluorescent conjugates and strip layout are selected and tested against the target.
02
Assay development
Strip, reagents and reader settings are optimized, and pilot lots are built.
03
Analytical validation
Precision, linearity, interference and lot-to-lot consistency are measured against reference methods.
04
Clinical evaluation and launch
Performance is evaluated with clinical samples. First release is planned for research use only, followed by regulatory submissions.
Related assays
Development status. This assay and the OncoFirm platform are in development. They have not been cleared or approved by the FDA and are not available for sale. First products are planned for research use only. Descriptions reflect design goals, not demonstrated performance.
Partner on this assay
We welcome research, clinical, manufacturing and distribution partners. Tell us how this assay fits your work.